Geoffrey Hird's Colleagues at Glycomine
Geoffrey Hird's Contact Details
HQ
650-401-2016
650-401-2016
Location
Durham, North Carolina, United States
Durham, North Carolina, United States
Company
Glycomine
Glycomine
Geoffrey Hird's Company Details
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine's lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Frequently Asked Questions about Geoffrey Hird
Geoffrey Hird currently works for Glycomine.
Geoffrey Hird's role at Glycomine is VP of Pharmaceutical Development and CMC.
Geoffrey Hird's email address is ***@glycomine.com. To view Geoffrey Hird's full email address, please signup to ConnectPlex.
Geoffrey Hird works in the BioTech/Drugs industry.
Geoffrey Hird's colleagues at Glycomine are Teppei Shirakura, Steven Axon, Tristen Moors, Karen Morici, Helen Shapiro, Hicham Alaoui, Timothy Mills and others.
Geoffrey Hird's phone number is 650-401-2016